Extended release oral clonidine suspension OK'd for ADHD in children

Onyda XR (clonidine hydrochloride) is a centrally acting alpha2-adrenergic agonist indicated for the treatment of ADHD as monotherapy or as an adjunct to stimulant medications in pediatric patients ≥6 years of age. Approval was based on studies of clonidine extended-release tablets. According to a manufacturer press release, Onyda XR is the first liquid non-stimulant ADHD medication approved in the U.S. and the only approved non-stimulant ADHD medication with nighttime dosing.